This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Stocks in play: HLS Therapeutics Inc.

Baystreet.ca - Baystreet - Thu Oct 30, 2025

Will release financial results for the three and nine months ended September 30, 2025, on Thursday, November 13. HLS Therapeutics Inc. shares T.HLS are trading unchanged at $5.40.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).